These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expansion of the Liver Donor Supply Through Greater Use of Split-Liver Transplantation: Identifying Optimal Recipients. Mogul DB, Luo X, Garonzik-Wang J, Bowring MG, Massie AB, Schwarz KB, Cameron AM, Bridges JFP, Segev DL. Liver Transpl; 2019 Jan; 25(1):119-127. PubMed ID: 30230191 [Abstract] [Full Text] [Related]
3. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation. Cherukuru R, Reddy MS, Shanmugam NP, Rajalingam R, Kota V, Gunasekaran V, Narasimhan G, Kaliamoorthy I, Rela M. Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233 [Abstract] [Full Text] [Related]
4. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area. Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM. Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743 [Abstract] [Full Text] [Related]
5. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients. Kling CE, Perkins JD, Reyes JD, Montenovo MI. Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730 [Abstract] [Full Text] [Related]
6. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation. Kollmann D, Sapisochin G, Goldaracena N, Hansen BE, Rajakumar R, Selzner N, Bhat M, McCluskey S, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M. Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237 [Abstract] [Full Text] [Related]
9. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Gordon FD, Goldberg DS, Goodrich NP, Lok AS, Verna EC, Selzner N, Stravitz RT, Merion RM. Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253 [Abstract] [Full Text] [Related]
10. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation. Alim A, Erdogan Y, Yuzer Y, Tokat Y, Oezcelik A. Liver Transpl; 2016 Dec; 22(12):1643-1648. PubMed ID: 27509534 [Abstract] [Full Text] [Related]
11. Combined Dual-Kidney Liver Transplantation in the United States: A Review of United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Between 2002 and 2012. Shekhtman G, Huang E, Danovitch GM, Martin P, Bunnapradist S. Liver Transpl; 2018 Nov; 24(11):1570-1577. PubMed ID: 29493877 [Abstract] [Full Text] [Related]
12. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia. Alexopoulos SP, Nekrasov V, Cao S, Groshen S, Kaur N, Genyk YS, Matsuoka L. Liver Transpl; 2017 Feb; 23(2):221-233. PubMed ID: 27862929 [Abstract] [Full Text] [Related]
13. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients. Croome KP, Lee DD, Burns JM, Saucedo-Crespo H, Perry DK, Nguyen JH, Taner CB, Mayo Clinic Collaborative in Transplant Research and Outcomes. Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067 [Abstract] [Full Text] [Related]
14. Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts. Macshut M, Kaido T, Yao S, Yagi S, Ito T, Kamo N, Nagai K, Sharshar M, Uemoto S. Liver Transpl; 2019 Oct; 25(10):1524-1532. PubMed ID: 31298473 [Abstract] [Full Text] [Related]
15. Right lobe living donors ages 55 years old and older in liver transplantation. Kim SH, Lee EC, Shim JR, Park SJ. Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130 [Abstract] [Full Text] [Related]
16. Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome. Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M. Liver Transpl; 2018 Nov; 24(11):1512-1522. PubMed ID: 30264930 [Abstract] [Full Text] [Related]
17. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort. Croome KP, Lee DD, Croome S, Nakhleh RE, Abader Sedki Senada P, Livingston D, Yataco M, Taner CB. Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923 [Abstract] [Full Text] [Related]
18. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. Lee WC, Chan KM, Chou HS, Wu TJ, Lee CF, Soong RS, Wu TH, Lee CS. Ann Surg; 2013 Aug; 258(2):306-11. PubMed ID: 23108123 [Abstract] [Full Text] [Related]
19. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics. Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW. Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434 [Abstract] [Full Text] [Related]
20. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation. Fukazawa K, Nishida S, Pretto EA, Vater Y, Reyes JD. J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):406-13. PubMed ID: 27108389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]